Oncotarget

Clinical Research Papers:

Clinical reports of surgical dislocation of the hip with sequestrum clearance and impacting bone graft for grade IIIA-IIIB aseptic necrosis of femoral head (ANFH) patients

Chen Yao, Nan Yi, Jirong Shen _, Bin Du, Guangquan Sun, Hao Shu and Chao Zhang

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:50084-50090. https://doi.org/10.18632/oncotarget.15095

Metrics: PDF 991 views  |   HTML 1362 views  |   ?  


Abstract

Chen Yao1,*, Nan Yi2,*, Jirong Shen1, Bin Du1, Guangquan Sun1 Hao Shu1 and Chao Zhang1

1 Orthopedics Joint Group, The Affiliated Hospital of Nanjing University of TCM, Jiangsu Province Hospital of TCM, Nanjing, China

2 Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China

* Co-first authors

Correspondence to:

Jirong Shen, email:

Keywords: surgical dislocation of the hip; aseptic necrosis of femoral head; impacting bone graft

Received: January 05, 2017 Accepted: January 25, 2017 Published: February 04, 2017

Abstract

Objective: To analyze the treatment effect of surgical dislocation of the hip with sequestrum clearance and impacting bone graft in grade IIIA-IIIB aseptic necrosis of femoral head (ANFH) patients. Methods: From June 2012 to December 2014, 6 patients (total 8 hips) with grade IIIA-IIIB ANFH were retrospectively followed. All the patients were operated with surgical dislocation of the hip with sequestrum clearance and impacting bone graft. Collapse of the femoral head, healing of the osteotomy, along with Harris hip scores were observed after surgeries. Results: All the patients were followed up, the osteotomies were all healed. Only 1 of the 8 hips (12.5%) was collapsed by the last follow-up. Harris hip scores were improved from 54.52 ± 8.16 to 80.53 ± 7.62 (P <0.001). The excellent rate was 87.5%. Conclusion: For grade IIIA-IIIB ANFH patients, surgical dislocation with sequestrum clearance and impacting bone graft could possibly achieve satisfactory clinical benefit, particularly for the young patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15095